Subscribe to RSS
DOI: 10.1055/a-2769-1363
AI Clinical Decision Tools in Multidisciplinary Team Discussions for Colorectal Cancer
Authors
Abstract
Multidisciplinary team (MDT) discussions have become a cornerstone of colorectal cancer (CRC) management, integrating the expertise of surgeons, oncologists, radiologists, pathologists, and allied health professionals to facilitate personalized, evidence-based care. However, increasing complexity in treatment options, particularly with the rise of neoadjuvant strategies and immunotherapies, has rendered decision-making more challenging. Traditional tools—including clinical guidelines, risk calculators, and nomograms—offer structured decision support but lack flexibility and personalization. Artificial intelligence (AI), particularly through machine learning (ML), radiomics, and large language models (LLMs), is emerging as a transformative adjunct to clinical decision-making in CRC. Machine learning models have demonstrated strong predictive performance for treatment response, recurrence risk, and surgical complications, while radiomics and deep learning have improved diagnostic accuracy and treatment response prediction using imaging and endoscopy. LLMs such as ChatGPT have shown promising concordance with MDT recommendations in early studies, especially for standard clinical scenarios. However, limitations remain in handling complex, nuanced cases. Despite their growing capabilities, AI and LLMs are not yet integrated into routine MDT workflows due to concerns about interpretability, regulatory oversight, and ethical challenges. Future directions include developing real-time, multimodal AI-MDT platforms, improving explainability, ensuring equitable data representation, and integrating AI training into medical education. This review outlines current evidence on AI integration within CRC MDTs, highlighting both its clinical potential and the barriers that must be addressed to ensure safe, effective, and equitable implementation. Ultimately, AI is poised to augment—not replace—human expertise, enhancing the consistency, efficiency, and personalization of multidisciplinary CRC care.
Keywords
colorectal cancer - multidisciplinary team discussion - artificial intelligence - large language modelsPublication History
Article published online:
30 December 2025
© 2025. Thieme. All rights reserved.
Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA
-
References
- 1 Gnanapandithan K, Pagán RJ, Cowart J. The Mayo brothers: pioneers of modern medicine and patient-centered care. Cureus 2024; 16 (10) e71269
- 2 Taberna M, Gil Moncayo F, Jané-Salas E. et al. The multidisciplinary team (MDT) approach and quality of care. Front Oncol 2020; 10: 85
- 3 Zhang H, Yu J, Wei Z, Wu W, Zhang C, He Y. The effect of multidisciplinary team discussion intervention on the prognosis of advanced colorectal cancer. J Cancer 2021; 12 (11) 3307-3314
- 4 Fehervari M, Hamrang-Yousefi S, Fadel MG. et al. A systematic review of colorectal multidisciplinary team meetings: an international comparison. BJS Open 2021; 5 (03) zrab044
- 5 Lucarini A, Garbarino GM, Orlandi P. et al; Sant'Andrea GLAM collaborative group. From “cure” to “care”: the role of the multidisciplinary team on colorectal cancer patients' satisfaction and oncological outcomes. J Multidiscip Healthc 2022; 15: 1415-1426
- 6 Fu J, Zhong X, Li N. et al. Deep learning-based radiomic features for improving neoadjuvant chemoradiation response prediction in locally advanced rectal cancer. Phys Med Biol 2020; 65 (07) 075001
- 7 Huang K, Das P, Olanrewaju AM. et al. Automation of radiation treatment planning for rectal cancer. J Appl Clin Med Phys 2022; 23 (09) e13712
- 8 Kotze PG. The essential role of a multidisciplinary approach in inflammatory bowel diseases. Clin Colon Rectal Surg 2022; 35 (01) 3-4
- 9 Benson AB, Venook AP, Adam M. et al. NCCN Guidelines® insights: rectal cancer, version 3.2024. J Natl Compr Canc Netw 2024; 22 (06) 366-375
- 10 You YN, Hardiman KM, Bafford A. et al; On Behalf of the Clinical Practice Guidelines Committee of the American Society of Colon and Rectal Surgeons. The American Society of Colon and Rectal Surgeons Clinical Practice Guidelines for the management of rectal cancer. Dis Colon Rectum 2020; 63 (09) 1191-1222
- 11 Hofheinz RD, Fokas E, Benhaim L. et al; ESMO Guidelines Committee. Electronic address: clinicalguidelines@esmo.org. Localised rectal cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up. Ann Oncol 2025; 36 (09) 1007-1024
- 12 McNelis J, Castaldi M. “The National Surgery Quality Improvement Project” (NSQIP): a new tool to increase patient safety and cost efficiency in a surgical intensive care unit. Patient Saf Surg 2014; 8: 19
- 13 Horzic M, Kopljar M, Cupurdija K, Bielen DV, Vergles D, Lackovic Z. Comparison of P-POSSUM and Cr-POSSUM scores in patients undergoing colorectal cancer resection. Arch Surg 2007; 142 (11) 1043-1048
- 14 Dourado J, Rogers P, Emile S. et al. Predictors of nodal positivity in clinically under-staged patients with colon cancer: a national cancer database study and proposal of a predictive scoring system. Am J Surg 2024; 235: 115777
- 15 Emile SH, Horesh N, Freund MR. et al. Surgical outcomes and predictors of overall survival of stage I-III appendiceal adenocarcinoma: retrospective cohort analysis of the national cancer database. Surg Oncol 2024; 52: 102034
- 16 Kawai K, Sunami E, Yamaguchi H. et al. Nomograms for colorectal cancer: a systematic review. World J Gastroenterol 2015; 21 (41) 11877-11886
- 17 Bibault JE, Giraud P, Burgun A. Big Data and machine learning in radiation oncology: state of the art and future prospects. Cancer Lett 2016; 382 (01) 110-117
- 18 Gennatas ED, Friedman JH, Ungar LH. et al. Expert-augmented machine learning. Proc Natl Acad Sci U S A 2020; 117 (09) 4571-4577
- 19 Miller MI, Shih LC, Kolachalama VB. Machine learning in clinical trials: a primer with applications to neurology. Neurotherapeutics 2023; 20 (04) 1066-1080
- 20 Endo Y, Alaimo L, Moazzam Z. et al. Optimal policy tree to assist in adjuvant therapy decision-making after resection of colorectal liver metastases. Surgery 2024; 175 (03) 645-653
- 21 Chen L, Wang Y, Cai C. et al. Machine learning predicts oxaliplatin benefit in early colon cancer. J Clin Oncol 2024; 42 (13) 1520-1530
- 22 Yothers G, O'Connell MJ, Allegra CJ. et al. Oxaliplatin as adjuvant therapy for colon cancer: updated results of NSABP C-07 trial, including survival and subset analyses. J Clin Oncol 2011; 29 (28) 3768-3774
- 23 Allegra CJ, Yothers G, O'Connell MJ. et al. Phase III trial assessing bevacizumab in stages II and III carcinoma of the colon: results of NSABP protocol C-08. J Clin Oncol 2011; 29 (01) 11-16
- 24 Woerner J, Nam Y, Jung SH. et al. Leveraging automated machine learning to predict colon cancer prognosis from clinical features and risk groups: a retrospective cohort study. Eur J Surg Oncol 2025; 51 (09) 110194
- 25 Yang S, Jang H, Park IK. et al. Machine-learning algorithms using systemic inflammatory markers to predict the oncologic outcomes of colorectal cancer after surgery. Ann Surg Oncol 2023; 30 (13) 8717-8726
- 26 Shao S, Zhao Y, Lu Q, Liu L, Mu L, Qin J. Artificial intelligence assists surgeons' decision-making of temporary ileostomy in patients with rectal cancer who have received anterior resection. Eur J Surg Oncol 2023; 49 (02) 433-439
- 27 Nellis JR, Sun Z, Chang B, Della Porta G, Mantyh CR. A risk-prediction platform for acute kidney injury and 30-day readmission after colorectal surgery. J Surg Res 2023; 292: 91-96
- 28 Emile SH, Horesh N, Garoufalia Z, Gefen R, Rogers P, Wexner SD. An artificial intelligence-designed predictive calculator of conversion from minimally invasive to open colectomy in colon cancer. Updates Surg 2024; 76 (04) 1321-1330
- 29 Bektaş M, Tuynman JB, Costa Pereira J, Burchell GL, van der Peet DL. Machine learning algorithms for predicting surgical outcomes after colorectal surgery: a systematic review. World J Surg 2022; 46 (12) 3100-3110
- 30 Chen R, Fu Y, Yi X, Pei Q, Zai H, Chen BT. Application of radiomics in predicting treatment response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer: strategies and challenges. J Oncol 2022; 2022: 1590620
- 31 Najjar R. Redefining radiology: a review of artificial intelligence integration in medical imaging. Diagnostics (Basel) 2023; 13 (17) 2760
- 32 Gillies RJ, Kinahan PE, Hricak H. Radiomics: images are more than pictures, they are data. Radiology 2016; 278 (02) 563-577
- 33 Avanzo M, Wei L, Stancanello J. et al. Machine and deep learning methods for radiomics. Med Phys 2020; 47 (05) e185-e202
- 34 Niu Y, Yu X, Wen L. et al. Comparison of preoperative CT- and MRI-based multiparametric radiomics in the prediction of lymph node metastasis in rectal cancer. Front Oncol 2023; 13: 1230698
- 35 Liu X, Yang Q, Zhang C. et al. Multiregional-based magnetic resonance imaging radiomics combined with clinical data improves efficacy in predicting lymph node metastasis of rectal cancer. Front Oncol 2021; 10: 585767
- 36 Shu Z, Mao D, Song Q, Xu Y, Pang P, Zhang Y. Multiparameter MRI-based radiomics for preoperative prediction of extramural venous invasion in rectal cancer. Eur Radiol 2022; 32 (02) 1002-1013
- 37 Sun Z, Xia F, Lv W, Li J, Zou Y, Wu J. Radiomics based on T2-weighted and diffusion-weighted MR imaging for preoperative prediction of tumor deposits in rectal cancer. Am J Surg 2024; 232: 59-67
- 38 Fan L, Wu H, Wu Y, Wu S, Zhao J, Zhu X. Preoperative prediction of rectal cancer staging combining MRI deep transfer learning, radiomics features, and clinical factors: accurate differentiation from stage T2 to T3. BMC Gastroenterol 2024; 24 (01) 247
- 39 Dong X, Ren G, Chen Y. et al. Effects of MRI radiomics combined with clinical data in evaluating lymph node metastasis in mrT1-3a staging rectal cancer. Front Oncol 2023; 13: 1194120
- 40 Liu Z, Zhang J, Wang H. et al. MRI-based radiomics feature combined with tumor markers to predict TN staging of rectal cancer. J Robot Surg 2024; 18 (01) 229
- 41 Li M, Sun K, Dai W. et al. Preoperative prediction of peritoneal metastasis in colorectal cancer using a clinical-radiomics model. Eur J Radiol 2020; 132: 109326
- 42 Zhang D, Zheng B, Xu L. et al. A radiomics-boosted deep-learning for risk assessment of synchronous peritoneal metastasis in colorectal cancer. Insights Imaging 2024; 15 (01) 150
- 43 Gefen R, Garoufalia Z, Horesh N. et al. How reliable is restaging MRI after neoadjuvant therapy in rectal cancer?. Colorectal Dis 2023; 25 (08) 1631-1637
- 44 Li Y, Liu X, Gu M, Xu T, Ge C, Chang P. Significance of MRI-based radiomics in predicting pathological complete response to neoadjuvant chemoradiotherapy of locally advanced rectal cancer: a narrative review. Cancer Radiother 2024; 28 (04) 390-401
- 45 Nie K, Shi L, Chen Q. et al. Rectal cancer: assessment of neoadjuvant chemoradiation outcome based on radiomics of multiparametric MRI. Clin Cancer Res 2016; 22 (21) 5256-5264
- 46 van Griethuysen JJM, Lambregts DMJ, Trebeschi S. et al. Radiomics performs comparable to morphologic assessment by expert radiologists for prediction of response to neoadjuvant chemoradiotherapy on baseline staging MRI in rectal cancer. Abdom Radiol (NY) 2020; 45 (03) 632-643
- 47 Ke J, Jin C, Tang J. et al. A longitudinal MRI-based artificial intelligence system to predict pathological complete response after neoadjuvant therapy in rectal cancer: a multicenter validation study. Dis Colon Rectum 2023; 66 (12) e1195-e1206
- 48 Cai L, Lambregts DMJ, Beets GL. et al. An automated deep learning pipeline for EMVI classification and response prediction of rectal cancer using baseline MRI: a multi-centre study. NPJ Precis Oncol 2024; 8 (01) 17 . Erratum in: NPJ Precis Oncol. 2025;9:45
- 49 Jong BK, Yu ZH, Hsu YJ, Chiang SF, You JF, Chern YJ. Deep learning algorithms for predicting pathological complete response in MRI of rectal cancer patients undergoing neoadjuvant chemoradiotherapy: a systematic review. Int J Colorectal Dis 2025; 40 (01) 19
- 50 Seretis F, Panagaki A, Tzamouri S, Triantafyllou T, Triantopoulou C, Theodorou D. Can radiomics predict pathologic complete response after neoadjuvant chemoradiotherapy for rectal cancer? A systematic review and meta-analysis of diagnostic-accuracy studies. J Pers Med 2025; 15 (06) 244
- 51 Stanzione A, Verde F, Romeo V, Boccadifuoco F, Mainenti PP, Maurea S. Radiomics and machine learning applications in rectal cancer: current update and future perspectives. World J Gastroenterol 2021; 27 (32) 5306-5321
- 52 Park DK, Kim EJ, Im JP. et al. A prospective multicenter randomized controlled trial on artificial intelligence assisted colonoscopy for enhanced polyp detection. Sci Rep 2024; 14 (01) 25453
- 53 Misawa M, Kudo SE. Current status of artificial intelligence use in colonoscopy. Digestion 2025; 106 (02) 138-145
- 54 Haak HE, Gao X, Maas M. et al. The use of deep learning on endoscopic images to assess the response of rectal cancer after chemoradiation. Surg Endosc 2022; 36 (05) 3592-3600
- 55 Leng X, Uddin KMS, Chapman Jr W. et al. Assessing rectal cancer treatment response using coregistered endorectal photoacoustic and US imaging paired with deep learning. Radiology 2021; 299 (02) 349-358
- 56 Zhou S, Xie Y, Feng X, Li Y, Shen L, Chen Y. Artificial intelligence in gastrointestinal cancer research: Image learning advances and applications. Cancer Lett 2025; 614: 217555
- 57 Xin Y, Zhang Q, Liu X, Li B, Mao T, Li X. Application of artificial intelligence in endoscopic gastrointestinal tumors. Front Oncol 2023; 13: 1239788
- 58 Lee K, Lee SH. Artificial intelligence-driven oncology clinical decision support system for multidisciplinary teams. Sensors (Basel) 2020; 20 (17) 4693
- 59 Horesh N, Emile SH, Gupta S. et al. Comparing the management recommendations of large language model and colorectal cancer multidisciplinary team: a pilot study. Dis Colon Rectum 2025; 68 (01) 41-47
- 60 Chatziisaak D, Burri P, Sparn M, Hahnloser D, Steffen T, Bischofberger S. Concordance of ChatGPT artificial intelligence decision-making in colorectal cancer multidisciplinary meetings: retrospective study. BJS Open 2025; 9 (03) zraf040
- 61 Choo JM, Ryu HS, Kim JS. et al. Conversational artificial intelligence (chatGPT™) in the management of complex colorectal cancer patients: early experience. ANZ J Surg 2024; 94 (03) 356-361
- 62 Karabuğa B, Karaçin C, Büyükkör M. et al. The role of artificial intelligence (ChatGPT-4o) in supporting tumor board decisions. J Clin Med 2025; 14 (10) 3535
- 63 Sorin V, Klang E, Sklair-Levy M. et al. Large language model (ChatGPT) as a support tool for breast tumor board. NPJ Breast Cancer 2023; 9 (01) 44
- 64 Lukac S, Dayan D, Fink V. et al. Evaluating ChatGPT as an adjunct for the multidisciplinary tumor board decision-making in primary breast cancer cases. Arch Gynecol Obstet 2023; 308 (06) 1831-1844
- 65 Murtada A, Kayali F, Jubouri M. et al. Artificial intelligence in colorectal surgery multidisciplinary team approach—from innovation to application. Physiol Rep 2025; 13 (08) e70319
- 66 Tjhin Y, Kewlani B, Singh HKSI, Pawa N. Artificial intelligence in colorectal multidisciplinary team meetings. What are the medicolegal implications?. Colorectal Dis 2024; 26 (09) 1749-1752
- 67 Quero G, Mascagni P, Kolbinger FR. et al. Artificial intelligence in colorectal cancer surgery: present and future perspectives. Cancers (Basel) 2022; 14 (15) 3803
- 68 Kao D, Larson C, Fletcher D, Stegner K. Clinical decision support may link multiple domains to improve patient care: viewpoint. JMIR Med Inform 2020; 8 (10) e20265
- 69 Martin KD, Zimmermann J. Artificial intelligence and its implications for data privacy. Curr Opin Psychol 2024; 58: 101829
- 70 Pantanowitz L, Hanna M, Pantanowitz J. et al. Regulatory aspects of artificial intelligence and machine learning. Mod Pathol 2024; 37 (12) 100609
- 71 Nardone V, Marmorino F, Germani MM. et al. The role of artificial intelligence on tumor boards: perspectives from surgeons, medical oncologists and radiation oncologists. Curr Oncol 2024; 31 (09) 4984-5007
